Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Korro Bio, Inc. (KRRO)

NASDAQ

$14.19

$-0.13

(-0.90%)

Pre-Market

Korro Bio, Inc. (KRRO) Live Price Chart

Last updated: ⁦2026-09-16 13:20:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Korro Bio, Inc. (KRRO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $14.19, with a market capitalisation of $204.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.20 to $55.89. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$204.39M
Open	$14.32
Day's High	$98.00
Day's Low	$5.20
Previous Close	$14.07
Volume	50.00
Average Volume	177.11K
P/E Ratio	--
52-Week High	$55.89
52-Week Low	$5.20
Dividend Yield	--
Earnings Date	--

Korro Bio, Inc. (KRRO) Pre-Market Stock Price

Korro Bio, Inc. (KRRO) is trading at $14.19 in pre-market trading as of 2026-09-16 11:45:00, up 0.86% ($0.12) from the previous close of $14.07

Pre-market trading shows how investors are pricing KRRO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Korro Bio, Inc. (KRRO) 7-Day Stock Price Change

Over the past seven days, Korro Bio, Inc. (KRRO) moved from $12.24 to $14.19, representing a gain of 15.94% ($1.95).

The stock traded between $11.53 and $15.15 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 157.18 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

KRRO 52-Week Price Position

Position in Range: 17.7%

52W Low$5.20

52W High$55.89

KRRO is currently trading at $14.19, placing it 17.7% of the way from its 52-week low of $5.20 to its 52-week high of $55.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Korro Bio, Inc. (KRRO)?

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Korro Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	57
Exchange	NASDAQ
Company Website	https://www.korrobio.com

How to Buy Korro Bio, Inc. (KRRO) Stock on MEXC

Eligible investors can buy real shares of Korro Bio, Inc. (KRRO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KRRO and Place Your Order

Open the RealStocks trading page and search for KRRO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Korro Bio, Inc. (KRRO) stock price today?

Korro Bio, Inc. (KRRO) is currently trading at $ 14.19, up 0.86% ($0.12) from the previous close of $ 14.07. Intraday prices update in real time during regular trading hours.

2.Is KRRO stock going up or down today?

As of 2026-09-16 11:45:00, KRRO is trading at $ 14.19, up 0.86% ($0.12) from its previous close of $ 14.07. The stock has traded between $ 5.20 and $ 98.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is KRRO pre-market price?

As of 2026-09-16 11:45:00, KRRO is trading at $ 14.19 in pre-market trading, up 0.86% ($0.12) from the previous close of $ 14.07. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KRRO after-hours price?

As of 2026-09-16 11:45:00, KRRO is trading at $ 14.35 in after-hours trading, up 1.95% ($0.28) from the regular-session close of $ 14.07. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KRRO stock trading now?

KRRO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KRRO sit relative to its 52-week high and low?

Over the past 52 weeks, KRRO has traded between a low of $ 5.20 and a high of $ 55.89. At $ 14.19, the stock is positioned 17.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Korro Bio, Inc. in?

Korro Bio, Inc. (KRRO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Korro Bio, Inc.'s market capitalisation and where is it listed?

Korro Bio, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 204.39M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KRRO valued in terms of P/E ratio and EPS?

KRRO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -7.24. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Korro Bio, Inc. pay a dividend?

Korro Bio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.